NewsBusinessGene purchaseTuesday 23 June 1998 19:02 EDTBookmarkCommentsGo to commentsBookmark popoverRemoved from bookmarksClose popoverGene purchaseCAMBRIDGE Antibody Technology, the gene screening group, yesterday bought Aptein Inc, a US technology company, for up to pounds 11m in shares.More aboutBiologyGeneticsHealthcareTechnologyJoin our commenting forumJoin thought-provoking conversations, follow other Independent readers and see their repliesComments
Bookmark popover
Removed from bookmarks